Competitors: | Synthes Acc.Inv. Sf-,001, Stryker, Johnson & Johnson, Zimmer Biomet Holdings Inc |
Registrars: | Equiniti |
Brands: | profix, cofield |
Independent Non-Executive Director: | Simon Lowth |
CEO: | Deepak Nath |
CFO: | John Rogers |
Independent Non-Executive Director: | Katarzyna Mazur Hofsaess |
Independent Non-Executive Director: | John Ma |
Independent Non-Executive Director: | Sybella Stanley |
Independent Non-Executive Director: | Jeremy (Jez) Maiden |
Independent Non-Executive Director: | Jo Hallas |
Independent Non-Executive Director: | Bob White |
Non-Executive Chairman: | Rupert Soames |
Senior Independent Director: | Angie Risley |
Non-Executive Dir: | Marc Owen |
Address: | Building 5, Croxley Park, Hatters Lane, Watford, Hertfordshire, United Kingdom, WD18 8YE |
Phone: | +44 (0)1923 477 100 |
Fax: | +44 (0) 20 7960 2350 |
Website: | http://www.smith-nephew.com |
Sector: | Health Care(LSE) |
Index: | techMARK, FTSE 100, FTSEurofirst 300, FTSE 350, FTSE All-Share, FTSE techMARK Focus |
Overseas Listings: | BATSLON:SNL |
ISIN: | GB0009223206 |
Currency | UK Pounds |
Share Price | 1,067.00p |
Change Today | -4.00p |
% Change | -0.37 % |
52 Week High | 1,208.50p |
52 Week Low | 917.60p |
Volume | 192,851 |
Shares Issued | 874.41m |
Market Cap | £9,330m |
Beta | 0.02 |
RiskGrade | 173 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 4 |
Buy | 4 |
Neutral | 10 |
Sell | 0 |
Strong Sell | 0 |
Total | 18 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 27-Mar-25 | 03-Oct-24 |
Paid | 28-May-25 | 08-Nov-24 |
Amount | 23.10¢ | 14.40¢ |
Time | Volume / Share Price |
11:35 | 532 @ 1,067.00p |
11:35 | 188 @ 1,066.66p |
11:34 | 162 @ 1,066.50p |
11:34 | 11 @ 1,067.50p |
11:32 | 663 @ 1,067.00p |
CEO | Deepak Nath |
CFO | John Rogers |
You are here: research